Genomic profiling of interferon signaling pathway gene mutations in type 2 diabetic individuals with COVID-19
Comorbidities, especially diabetes, significantly contribute to the mortality and morbidity of COVID-19. Studies indicate higher rates of mortality and morbidity among diabetic COVID-19 patients compared to the general population. However, the precise mechanisms underlying this immune response remai...
Saved in:
| Main Authors: | Tuluk Tuncay, Kankılıç Teoman, Civelek İlkay, Akın Dilara Fatma, Bankır Mehmet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2024-12-01
|
| Series: | Türk Biyokimya Dergisi |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/tjb-2024-0139 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interference without interferon: interferon-independent induction of interferon-stimulated genes and its role in cellular innate immunity
by: Shachee Swaraj, et al.
Published: (2024-10-01) -
Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities
by: James Tumlin, et al.
Published: (2025-01-01) -
Avian interferon regulatory factor (IRF) family reunion: IRF3 and IRF9 found
by: Lenka Ungrová, et al.
Published: (2025-07-01) -
Research progress on the mechanisms of CSF3R mutations in leukemogenesis and treatment strategies
by: Ningxuan Wang, et al.
Published: (2025-08-01) -
Mutational accumulation drives pathway dysregulation to predict glioma patient survival
by: Mengjiao Wan, et al.
Published: (2025-07-01)